Black Diamond Therapeutics, Inc. (BDTX) income statement
BDTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.31−0.08 (-5.76%)
Close on Nov 20, 2026Market cap $75.26MP/E –Yield –
Black Diamond Therapeutics, Inc. financial ratios
See a number that looks wrong?